- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04963127
Prospective Study of Diagnostic Accuracy of Spectral CT for the Detection of Bone Marrow Edema
November 21, 2023 updated by: University Hospital Augsburg
Prospective Observational Study of Diagnostic Accuracy of Dual-Energy-/Multi-Energy-CT for the Detection of Bone Marrow Edema
Dual-Energy/Multi-Energy/Spectral-CT can visualize bone marrow edema associated with fractures, however, current scientific evidence is mostly derived from to retrospective analyses.
Our prospective study systematically analyzes the diagnostic accuracy of the visualization of bone marrow edema by including patients who are scheduled for a CT scan to exclude or further characterize a fracture.
After giving informed consent, the CT scan will be performed using a dose-neutral Dual-Energy-/Multi-Energy-/Spectral-CT acquisition technique.
If the patient undergoes MRI of the same region within 7 days, this scan will be used as a gold-standard for bone marrow edema.
This will allow the quantification of diagnostic accuracy.
Study Overview
Status
Recruiting
Conditions
Study Type
Observational
Enrollment (Estimated)
800
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Schwarz, MD
- Phone Number: +498214002441
- Email: radiologie-studien@uk-augsburg.de
Study Locations
-
-
Bavaria
-
Augsburg, Bavaria, Germany, 86156
- Recruiting
- University Hospital Augsburg
-
Contact:
- Florian Schwarz, MD
- Phone Number: +498214002441
- Email: radiologie-studien@uk-augsburg.de
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
60 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Sampling Method
Probability Sample
Study Population
Patients who are at least 18 years of age who are referred by the emergency department for a CT scan with the suspicion of a fracture.
Description
Inclusion Criteria:
- clinical suspicion for a fracture AND
- indication for CT confirmed by board-certified radiologist ('justified indication' according to German/European radiation protection law) AND
- patient (is able to give informed consent and) has given informed consent.
Exclusion Criteria:
- cardiorespiratory instability (as judged by the referring physician)
- age < 18 years
- known or suspected pregnancy
- known bone metastases of a malignant disease
- known rheumatic disease
- metal implants in the region to be scanned
- surgical intervention over the last 12 months in the region to be scanned
- contraindications for MRI
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Other
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Prospective Cohort
400 patients who are scheduled to undergo a clinically requested CT scan of parts of the skeleton using a Dual-Energy/Multi-Energy/Spectral acquisition mode to exclude or further define bone fractures.
|
CT acquisition using a Dual-Energy / Multi-Energy / Spectral acquisition mode
Other Names:
|
|
Retrospective Cohort
400 patients who had undergone a clinically requested CT scan of the skeleton in standard acquisition mode in the past to exclude or further define bone fractures.
|
CT acquisition using a standard single energy / non-spectral acquisition mode
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Diagnostic Accuracy of Dual-Energy/Multi-Energy/Spectral CT to detect bone marrow edema in comparison with MRI as the goldstandard.
Time Frame: MRI of the same region can be used for comparison if performed within 7 days
|
sensitivity, specificity and positive and negative likelihood ratios will be assessed
|
MRI of the same region can be used for comparison if performed within 7 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Schwarz, MD, University Hospital Augsburg
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 15, 2021
Primary Completion (Estimated)
May 31, 2025
Study Completion (Estimated)
May 31, 2025
Study Registration Dates
First Submitted
July 5, 2021
First Submitted That Met QC Criteria
July 5, 2021
First Posted (Actual)
July 15, 2021
Study Record Updates
Last Update Posted (Estimated)
November 22, 2023
Last Update Submitted That Met QC Criteria
November 21, 2023
Last Verified
November 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 21-0318
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
We plan to share individual participant data upon request (pending final approval by the data protection officer of the university hospital).
IPD Sharing Time Frame
Requests for sharing individual participant data will be considered at the time of publication of the first manuscript containing result data.
IPD Sharing Access Criteria
We plan to share data on request at this point in time.
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Fractures, Bone
-
Jen-Chieh LaiCompleted
-
Shahid Beheshti University of Medical SciencesRecruiting
-
Lawson Health Research InstituteCompleted
-
Artur Salgado SANAMSARecruitingBone Loss | Bone Fractures | Bone Defects | Bone GraftPortugal
-
AO Innovation Translation CenterActive, not recruitingLong Bone FracturesCanada, United States, Australia, Croatia, Chile, Spain, Venezuela, Ghana, Pakistan, Germany, India, Greece
-
Brigham and Women's HospitalNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)Active, not recruitingFractures | Bone Density | Bone HealthUnited States
-
University Hospital, Clermont-FerrandTerminated
-
IlluminOss Medical, Inc.CompletedHumerus Fracture Metastatic Bone DiseaseUnited States
-
University of British ColumbiaCompleted
-
Centre Hospitalier Universitaire Saint PierreRecruiting
Clinical Trials on Computed Tomography of the skeleton using a Dual-Energy-/Multi-Energy-/Spectral acquisition mode
-
Punam K SahaNational Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health...CompletedPulmonary Disease, Chronic Obstructive | OsteoporosisUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingRichter Syndrome | Transformed Chronic Lymphocytic Leukemia to Diffuse Large B-Cell Lymphoma | Recurrent Transformed Chronic Lymphocytic Leukemia | Refractory Transformed Chronic Lymphocytic LeukemiaUnited States
-
National Cancer Institute (NCI)NRG OncologyCompletedStage III Lung Cancer AJCC v8 | Stage II Lung Cancer AJCC v8 | Unresectable Lung Non-Small Cell Carcinoma | Locally Advanced Lung Non-Small Cell Carcinoma | Locally Recurrent Lung Non-Small Cell CarcinomaUnited States
-
National Cancer Institute (NCI)RecruitingStage IV Nasopharyngeal Carcinoma AJCC v8 | Stage II Nasopharyngeal Carcinoma AJCC v8 | Stage III Nasopharyngeal Carcinoma AJCC v8United States, Puerto Rico, Canada, New Zealand
-
Children's Oncology GroupRecruiting
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingAcute Myeloid Leukemia | Acute Lymphoblastic Leukemia | Myelodysplastic SyndromeUnited States
-
National Cancer Institute (NCI)RecruitingNeuroblastoma | Ganglioneuroblastoma, NodularUnited States, Canada, Puerto Rico, Australia, New Zealand